Q1 2023 Holdings
Filed 2023-05-15 | 83 holdings | $3.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $12.0K | 99,999 | 0.0% |
| Reunion Neuroscience Inc | COM | 76134G103 | $104.3K | 151,098 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $761.4K | 325,400 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $1.6M | 602,500 | 0.1% |
| Caremax Inc | COM CL A | 14171W103 | $2.0M | 755,329 | 0.1% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $2.2M | 1,503,754 | 0.1% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $2.4M | 904,630 | 0.1% |
| Cyteir Therapeutics Inc | COM | 23284P103 | $3.2M | 1,764,100 | 0.1% |
| Praxis Precision Medicines I | COM | 74006W108 | $3.5M | 4,281,700 | 0.1% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $4.3M | 2,470,000 | 0.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $4.4M | 1,268,100 | 0.1% |
| Geron Corp(GERN) | COM | 374163103 | $4.6M | 2,128,000 | 0.2% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $5.6M | 1,315,200 | 0.2% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $6.0M | 1,825,000 | 0.2% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $7.1M | 723,200 | 0.2% |
| Kinnate Biopharma Inc | COM | 49705R105 | $7.3M | 1,160,000 | 0.2% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $7.6M | 989,500 | 0.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $8.9M | 252,000 | 0.3% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $9.2M | 385,500 | 0.3% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $12.4M | 819,000 | 0.4% |
| Natera Inc(NTRA) | COM | 632307104 | $13.9M | 249,900 | 0.5% |
| Mersana Therapeutics Inc | COM | 59045L106 | $14.1M | 3,433,233 | 0.5% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $14.6M | 2,048,600 | 0.5% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $14.6M | 2,758,600 | 0.5% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $15.5M | 417,000 | 0.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $16.2M | 1,043,000 | 0.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $16.6M | 1,000,000 | 0.6% |
| Dexcom Inc(DXCM) | COM | 252131107 | $17.2M | 148,000 | 0.6% |
| Point Biopharma Global Inc | COM | 730541109 | $17.5M | 2,411,600 | 0.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $17.6M | 878,800 | 0.6% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $17.9M | 1,628,500 | 0.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $19.1M | 510,000 | 0.6% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $19.4M | 1,265,545 | 0.6% |
| Verve Therapeutics Inc | COM | 92539P101 | $19.5M | 1,351,700 | 0.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $19.8M | 1,263,800 | 0.7% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $20.3M | 126,600 | 0.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $20.3M | 1,487,200 | 0.7% |
| Kezar Life Sciences Inc | COM | 49372L100 | $20.4M | 6,519,400 | 0.7% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $21.3M | 1,244,400 | 0.7% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $21.5M | 5,700,000 | 0.7% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $21.9M | 2,217,000 | 0.7% |
| Avantor Inc(AVTR) | COM | 05352A100 | $23.8M | 1,125,000 | 0.8% |
| Curevac N V | COM | N2451R105 | $24.7M | 3,550,000 | 0.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $26.4M | 900,000 | 0.9% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $28.1M | 1,842,976 | 0.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $29.1M | 1,344,800 | 1.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $29.2M | 300,575 | 1.0% |
| Icon PLC(ICLR) | SHS | G4705A100 | $30.5M | 142,900 | 1.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $32.8M | 4,553,577 | 1.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $35.8M | 128,800 | 1.2% |